Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 24Neoplasm Metastasis 7Neoplasms 5Prostate Cancer Metastatic 4Carcinoma, Transitional Cell 4Recurrence 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Carcinoma, Squamous Cell 2Carcinoma, Non-Small-Cell Lung 2Solid Cancer 1Small Cell Lung Carcinoma 1Penile Neoplasms 1Ovarian Neoplasms 1Nonseminomatous germ cell tumor 1Neoplastic Cells, Circulating 1Metastatic Castration-resistant Prostate Cancer 1Malignant Solid Tumor - Malignant Nervous System Neoplasm 1Lymphadenopathy 1Liposarcoma 1Hormone Refractory Prostate Cancer 1Head and Neck Neoplasms 1Glioblastoma 1Breast Neoplasms 1Bone Metastatic Prostate Cancer 1Advanced Solid Tumor 1

Interventions

enzalutamide 2radium Ra 223 dichloride 1poly ICLC 1olaparib 1fluciclovine F-18 1cabazitaxel 1bempegaldesleukin 1afuresertib 1Radiosurgery 1Radionuclide Imaging 1Prednisone 1Nivolumab 1Docetaxel 1Clinical Trials, Phase I as Topic 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Metastatic Castration-resistant Prostate Cancer × cabazitaxel × Clear all
NCT02044354 2026-04-01

CABA-DOC

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed
195 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡